American Heart Journal 2003: Vol 145 Index

31 Pages·2003·10 MB·English

dobutamine versus milrinone therapy in hospitalized patients
Author index*
awaiting cardiac transplantation prospective, randomized
trial. 2003;145:324-9
Arens HA (see Mitrovic et al). 2003:145:e14
oN Argano C (see Licata et al). 2004:145:459-66
Armstrong PW (see Al-Khatib et al). 2004:145:515 ; l
Abdelhamed Al, Reis SE, Sane DC, Brosnihan KB, Preli RB, Her Armstrong PW (see Batchelor et al). 2004:145:349-55
rington DM. No effect of an L-arginine- enriched medical food Armstrong PW (see Welsh et al). 2003:145:1-8 (Progress cardiol.)
(HeartBars) on endothelial function and platelet aggregation in Arnett DK (see Palmieri et al). 2003:145: 1071-7
subjects with hypercholesterolemia. 2003;145:e15 Ashfaq S (see Ghazzal et al). 2003:145: 1006-12
Abedin M, McGuire DK. Don’t miss this opportunity: diagnosing Attenhofer Jost CH. Pellikka PA. Atropine for inconclusive exercise
diabetes. 2003;145:195-7 (Editorial) tests: a beautiful solution or just cosmetics? 2004:145:938-40
Abouzhar L (see Crystal et al). 2003;145:174-8 (Trial design) (Editorial)
Abt B (see Unverdorben et al). 2003;145:¢17 Auer J, Berent R, Weber T, Eber B. Cytomegalovirus seropositivity
Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist infectious burden, and coronary artery disease. 2004:145:e9
in Congestive Heart Failure (ACTIV in CHF) Investigators (see (Letter)
Gheorghiade et al). 2003;145:551-4
Austin PC, Tu JV, Alter DA. Comparing hierarchical modeling with
Adamowicz-Czoch E (see Poloski et al). 2004:145:855-61 traditional logistic regression analysis among patients hospital
Adams-Campbell LL (see Khurana et al). 2003;145:724-9 ized with acute myocardial infarction: should we be analyzing
Adams KF Jr, Mathur VS, Gheorghiade M. B-Type natriuretic pep cardiovascular uutcomes data differently? 2003:145 7.35
tide: from bench to bedside. 2003;145:834-46 AveGrM s(se e Fry nan et al). 2004:145:670-5
Adams KF Jr (see Felker et al). 2003;145:518-25
Adams KF Jr (see Gheorghiade et al). 2003;145:S1-2, $51-4, $55
SO07-70
Adams KF Jr (see O'Connor et al). 2003:145:847-50
Adams KF Jr (see Zampino et al). 2003;145:862-6
Adgey AAJ (see Menown et al). 2003:145:986-92
Agranat O (see Goldenberg et al). 2003;145:862-7 Baer FM (see Schneider
Ahmed A, Allman RM, Kiefe CI, Person SD, Shanevfelt TM, Sims RV Baggi JM Ir (see Maia et
Howard G, DeLong JF. Association of consultation between Bahit MC. Cannor > Antman EM urphy SA, Gibson CM, Mc
generalists and cardiologists with quality and outcomes of heart Cabe CH, Braunwald E. Direct comparison of characteristics
failure care. 2003:145:1086-93 treatment, and outcomes of patients enrolled versus patients
Ahn YS (see Bernal-Mizrachi et al). 2004;145:962-70 (Progress car not enrolled in a clinical trial at centers participatingi n the TIMI
diol 9 Trial and vgistry. 2003:145: 109-17
Airoldi F (see Briguori et al). 2003;145:700-7 BairT L (see Jackson et al). 2003:145:875-81
Akyurek O, Berkalp B, Sayyn T, Kumbasar D, Kervanciolu C, Oral D Bairos L (see Pescatello 2003:145:364-70
Altered coronary flow properties in diffuse coronary artery Banai S$ (see Almagor et al 5:248-53
ectasia. 2003;145:66-72 Bang A (see Engdahl
Alegria E (see Mitrovic et al). 2003:145:e14 Banuelos C (see Alf
Alexander JH (see Serebruany et al). 2003:145:636-42 garam S$, McCrindle \. Hat Ben LN. Freedom RM, Ny
Alexander K (see Frazier and Alexander). 2003; 145:206-8 (Editorial) kanen DG. Outcon f uncomplic: 1 aortic valve stenosis
Alexander KP (see Pasquali et al). 2003;145:445-51 presenting
Alexopoulos D, Toulgaridis T, Davlouros P, Christodoulou J, Sitafi Jarbagelata A (see ecorgl le et al). 2 i
dis G, Hahalis G. Vagenakis AG. Prognostic significance of Barnard MR (s¢
coronary artery calcium in asymptomatic subjects with usual Bashore TM (see Lapevre ¢ ly. 20 145:10517
cardiovascular risk. 2003;145:542-8 Batchelor WB, Mark Granger CB, Armstrong PW
Alfonso F, Garcia P, Pimentel G, Hernndez R, Sabate M, Escaned J Califf RM. Petersor De pm ind validatioonf a simple
Banuclos C, Fernndez C, Macaya C. Predictors and implications model to pr irtery disease after myocardial
of residual plaque burden after coronary stenting: an intravas infarction: potential pa n cardiac catheterization use in
cular ultrasound study. 2003;145:254-61 the United Sta nd vada. 2003:145:349-55
4 (see Hasdai et al) 145 )
Alford AB (see Gurbel et al). 2003:145:239-47
Allman RM (see Ahmed et al). 2003:145: 1086-93 Bauriedel G, Skowas« } id M. Andrié R. Jabs A. Liideritz
Almagor M, Keren A, Banai S. Increased C-reactive protein level B. Antiplatel tensin-converting enzyme inhibi
after coronary stent implantation in patients with stable coro tors Compared With aspirin opidogrel: a pilot study with
Alonnsaory R ar(tseere y Mdoizseaass e. et 2al0)0. 3;2104053:;21484-55:3949 9-1005 Becwkh Col e(s-ebe looSidm psaong greegt ometry 2 §5°:144358°-34444 48
Alter DA (see Austin et al). 2003;145:27-35 Behrendt D (see 2003:145:426
Bell CR (see Gurbel et al). 2003:145:239-4
Ambrosioni E (see Borghi et al). 2003;145:80-7
Amin J (see Padmanabhan et al). 2003;145:132-8 BelIlN a(s ee Castel t 2003:145°53
Anderson JL (see Jackson et al). 2003:145:875-81 Bella IN (see Palmiet t al). 2004:1
Andrie R (see Bauriedel et al). 2003;145:343-8 Ben-Ami M (see
Annex BH (see Ketevian et al). 2003;145:912-18 Bengolea V (see
Annex BH (see Rajagopalan et al). 2003;145:1114-18 Benson LN (see
Ansari MN (see Massie and Ansari). 2003;145:209-13 (Editorial) Bentley ] (see Cotter
Antman EM (see Bahit et al). 2003;145: 109-17 Benun J, Fisher SD, Orav EJ. Schwartz ML, Exil V. Messere ¢
Apstein CS (see Ekery et al). 2003;145:896-902 Lipshultz SE. Cardiac management by pediatricians versus pedi
Aranda JM Jr. Schofield RS, Pauly DF, Cleeton TS, Walker T¢ atric cardiologists in an inpatient academic center. 2003:145
Monroe VS Jr, Leach D, Lopez LM, Hill JA. Comparison of 424-9
BeohaN r(se e Ricciardi et al). 2003:145:522-8
Berent R (see Auer et al). 2003:145:¢9 (Letter)
Berezin R (see
Berezin R (see
June 2003 American Heart Journal 1119
Berger P (see Steinhubl and Berger). 2003;145:971-8 (Progress Brassard P, Bourgault C, Brophy J, Kezouh A, Rainville B, Xhignesse
cardiol.) M, Suissa S$. Antibiotics in primary prevention of myocardiai
Berkalp B (see Akyurek et al). 2003;145:06-72 infarction among elderly patients with hypertension. 2003;145
Berlin JA (see Kizer et al). 2003;145:683-92 e25
Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J,M auro LM, Horstman Braunwald E (see Bahit et al). 2003;145:109-17
LL, de Marchena E, Ahn YS. High levels of circulating endothe- Braunwald E (see Cotter et al). 2003;145:622-7
lial microparticles in patients with acute coronary syndromes. Brawner CA (see Keteyian et al). 2003;145:912-18
2003: 145:962-70 (Progress cardiol.) BrickerJT (see Rivenes et al). 2003:145:716-23
Berry DA, Berry SM, McKellar J, Pearson TA. Comparison of the Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F, Sgura F, Spanos
dose-response relationships of 2 lipid-lowering agents: a Bayes- V, Carlino M, Montorfano M, Di Mario C, Colombo A. Elective
ian meta-analysis. 2003;145: 1036-45 versus provisional intra-aortic balloon pumping in high-risk per-
Berry SM (see Berry et al). 2003:145:1036-45 cutaneous transluminal coronary angioplasty. 2003;145:700-7
Berthold HK (see Unverdorben et al). 2003;145:e17 Brindis RG, Sennett C. Physician adherence to clinical practice
Berton G, Cordiano R, Palmieri R, Pianca S$, Pagliara V, Palatini P. guidelines: does it really matter? 2003;145:13-15 (Editorial)
C-Reactive protein in acute myocardial infarction: association Broderick TM (see Furman et al). 2003:145:e6
with heart failure. 2003;145:1094-101 Brodie BR, Stuckey TD, Muncy DB, Hansen CJ, Wall TC, Pulsipher
Best L (see Palmieri et al). 2003;145:467-74 M, Gupta N. Importance of time-to-reperfusion in patients with
Best PJM, Holmes DR Jr. Chronic kidney disease as a cardiovascular acute myocardial infarction with and without cardiogenic shock
risk factor. 2003; 145:383-6 (Editorial) treated with primary percutaneous coronary intervention
2003; 145:708-15
Bhatt DL (see Gerschutz and Bhatt). 2003;145:595-601 (Progress
Brophy J (see Brassard et al). 2003;145:e25
cardiol.)
Brosnihan KB (see Abdelhamed et al). 2003:145:e15
Binbrek A (see Serebruany et al). 2003;145:636-42
Browett PJ (see French et al). 2003;145:118-24
Birkmeyer NJO (see Nowicki et al). 2003;145:1058-62
Bruckman D (see Kim et al). 2003:145:665-9
Blatt A (see Cotter et al). 2003;145:622-7
Buchbinder M (see Mauri et al). 2003:145:847-54
Blebea J (see Rajagopalan et al). 2003;145:1114-18
Buchthal S (see Marroquin et al). 2003;145:628-35
Bloemenkamp DGM, Mali WPThM, Visseren FLJ, van der Graaf Y.
Bui S (see Mazeika et al). 2003;145:1013-21
Meta-analysis of sero-epidemiologic studies of the relation be-
Bunch TJ (see Jackson et al). 2003;145:875-81
tween Chlamydia pneumoniae and atherosclerosis: does study
design influence results? 2003;145:409-17 (Progress cardiol.)
Blum A, Lang N. Peleg A, Vigder F, Israeli P, Gumanovsky M,
Lupovitz S$, Elgazi A, Ben-Ami M. Effects of oral soy protein on Cc
markers of inflammation in postmenopausal women with mild
hypercholesterolemia. 2003; 145:e7 radena CN (see Oropeza and Cadena). 2003:145:317-23
Bode F (see Bonnemeier et al). 2003;145:484-92 -aliff RM (see Al-Khatib et al). 2003;145:515-21
Boehm BO (see Taubert et al). 2003;145:285-91 califf RM (see Batchelor et al). 2003:145:349-55
Bonnemeier H, Wiegand UKH, Giannitsis E, Schulenburg S$, Hart- -aliff RM (see Reddan et al). 2003:145:586-94 (Curriculum cardiol.)
mann F, Kurowski V, Bode F, Tolg R, Katus HA, Richardt G. allahan KP (see Serebruany et al). 2003;145:636-42
Temporal repolarization inhomogeneity and reperfusion ar- valvar C (see Ruiz et al). 2003;145:834-40
rhythmias in patients undergoing successful primary percutane- vampana C (see Gavazzi et al). 2003:145:310-16
ous coronary intervention for acute ST-segment elevation myo- ampeau L (see Knatterud et al). 2003;145:262-9
cardial infarction: impact of admission troponin T. 2003;145: ARR‘RaAnRaRd iaAn APAr ospective RandOmized Flosequinan Longevity Evalua-
484-92 tion (PROFILE) Investigators (see Rouleau et al). 2003:145:
926-32
Bonow RO (see Ricciardi et al). 2003;145:522-8
‘annon CP (see Bahit et al). 2003:145:109-17
Bonz AW, Lengenfelder B, Jacobs M, Strotmann J, Held S, Ertl G
-annon CP (see Cotter et al). 2003:145:622-7
Voelker W. Cytokine response after percutaneous coronary
ardinale A (see Licata et al). 2003;145:459-66
intervention in stable angina: effect of selective glycoprotein
‘arlino M (see Briguori et al). 2003:145:700-7
lib/Illa receptor antagonism. 2003;145:693-9
arroll $ (see Connolly et al). 2003;145:226-32
Booth JV, Phillips-Bute B, McCants CB, Podgoreanu MV, Smith PK,
aspi A (see Cotter et al). 2003:145:622-7
Mathew JP, Newman MF. Low serum magnesium levei predicts
asscells W, Hassan K, Vaseghi MF, Siadaty MS, Naghavi M, Kirkee
major adverse cardiac events after coronary artery bypass graft
ide RL, Hassan MR, Madjid M. Plaque blush, branch location
surgery. 2003;145:1108-13
and calcification are angiographic predictors of progression of
Boothroyd DB (see Melsop et al). 2003;145:36-41
mild to moderate coronary stenoses. 2003;145:813-20
Borges-Neto S (see Bourque et al). 2003;145:758-67 (Curriculum
vastello R, Bella JN, Rovner A, Swan J, Smith J, Shaw L. Efficacy and
cardiol.)
time-efficiency of a “sonographer-driven” contrast echocardiog-
Borghi C, Ambrosioni E, SMILE-2 Working Party. Double-blind com-
raphy protocol in a high-volume echocardiography laboratory
parison between zofenopril and lisinopril in patients with acute 2003;145:535-41
myocardial infarction: results of the Survival of Myocardial In- castillo S (see Mozas et al). 2003:145:999-1005
farction Long-term Evaluation-2 (SMILE-2) study. 2003;145:80-7 ‘elentano A (see Palmieri et al). 2003:145:467-74
Bosimini E (see Mezzani et al). 2003;145:1102-7 enarro A (see Mozas et al). 2003:145:999-1005
Botkin SB, Dhanekula LS, Olshansky B. Outpatient cardioversion of shanner KS (see Pugh et al). 2003;145:e11 (Letter)
atrial arrhythmias: efficacy, safety, and costs. 2003;145:233-8 tharlesworth A (see Cotter et al). 2003;145:622-7
Bourgault C (see Brassard et al). 2003;145:e25 shazin-Caldie M (see Kandzari et al). 2003:145:868-74
Bourque JM, Velazquez EJ, Borges-Neto S$, Shaw LK, Whellan DJ, then Y-T (see Chou et al). 2003:145:169-73
O'Connor CM. Radionuclide viability testing: should it affect shirife R (see Ruiz et al). 2003;145:834-40
treatment strategy in patients with cardiomyopathy and signif- ‘ho §$ (see Partington et al). 2003:145:139-46
icant Coronary artery disease? 2003; 145:758-67 (Curriculum car- hou H-T, Chen Y-T, Shi Y-R, Tsai F-J. Association between angio-
diol.) tensin I-converting enzyme gene insertion/deletion polymor
Boutchee KL (see Ting et al). 2003;145:278-84 phism and mitral valve prolapse syndrome. 2003:145:169-73
Bradley WA (see Piper et al). 2003;145:1022-9 chow C-M (see Fox et al). 2003:145:730-6
Brandi JM (see Maia et al). 2003;145:e27 christian TF (see Lapeyre et al). 2003;145:357-63
hristodoulou J (see Alexopoulos et al). 2003;145:542-8 Daemgen G (see Unverdorben et al). 2003:145:e17
hun S (see Partington et al). 2003;145:139-46 Dahlof B (see Oikarinen et al). 2003:145:919-25
iewierz D (see Gruchaa et al). 2003;145:125-31 Daley JR (see Lapeyre et al). 2003:145:357-63
iveira F (see Mozas et al). 2003;145:999-1005 Dalsey WC (see Hillis et al). 2003:145:88-94
lark LT. Treating dyslipidemia with statins: the risk-benefit profile Danoff TM (see Holmes and Danoff). 2003;145:e22 (Letter reply)
2003: 145:387-96 (Curriculum cardiol.) Darpo B (see Frykman et al). 2003:145:670-5
leeton TS (see Aranda et al). 2003;145:324-9 Davidoff R (see Ekery et al). 2003:145:896-902
lough RA (see Nowicki et al). 2003;145:1058-62 Davidson CJ (see Ricciardi et al). 2003:145:522-8
oats AJS (see Russell et al). 2003;145:179-86 (Trial design) Davlouros P (see Alexopoulos et al). 2003;145:542-8
oen MM (see Marso et al). 2003;145:270-7 Dawn B (see Stoddard et al). 2003:145:676-82
offman CJ (see Indridason et al). 2003;145:300-9 De Caterina R (see Gianetti and De Caterina). 2004;145:e13 (Letter
ohen DJ (see Reynolds et al). 2003;145:334-42 reply)
ohen DJ (see Taira et al). 2003;145:452-8 de Godoy MF (see Maia et al). 2004:145:e27
ol JJ (see Al-Shwafi et al). 2003;145:217-25 (Progress cardiol.) de Lemos JA (see Morrow and de Lemos). 2004:145:4380-2 (Editori-
olan SD (see Rivenes et a!). 2003;145:716-23 al)
ollins V (see Pescatello et al). 2003;145:364-70 de Marchena E (see Bernal-Mizrachi et al). 20043:145:962-70
olombo A (see Briguori et al). 2003;145:700-7 (Progress cardiol.)
onard M (see Haddock et al). 2003;145:652-7 de Meester A (see Al-Shwafi et al). 2003:145:217-25 (Progress car-
A~AAoAnRnAo AlAly APSAJ, rCybulRsky IA, Lam y A, Roberts RS, O’Brien B, Carroll $ diol.)
Crystal E, Thorpe KE, Gent M. Double-blind, placebo-con de Simone G (see Palmieri et al). 2003:145:467-74
trolled, randomized trial of prophylactic metoprolol for reduc- Decena BF (see Kim et al). 2003:145:665-9
tion of hospital length of stay after heart surgery: the 6-Blocker Degenhardt R (see Unverdorben et al). 2003;145:e17
Length Of Stay (BLOS) study. 2003;145:226-32 Dei Cas L (see Metra et al). 2003;145:292-9
onnolly SJ. Preventing stroke in patients with atrial fibrillation DeLong E. Hierarchical modeling: its time has come. 2003;145
current treatments and new concepts. 2003;145:418-23 16-18 (Editorial)
(Progress cardiol.) DeLongJ F (see Ahmed et al). 2003:145:1086-93
( onnolly SJ (see Crystal et al). 2003;145:174-8 (Trial design) Dens J, Desmet W, Piessens J. An updated meta-analysis of calcium-
( onnolly SJ (see Newman et al). 2003;145:430-7 channel blockers in the prevention of restenosis after coronary
( ooke G (see French et al). 2003;145:118-24 angioplasty. 2003:145:404-8 (Progress cardiol.)
( oombs LP (see Pasquali et al). 2003;145:445-51 Dery J-P. Hernandez AF, Kay JD, Petersen JL, Rao SV, Rebeiz AG,
( ordeiro JA (see Maia et al). 2003;145:e27 Singh KP, Donahue MP. Highlights from the American Heart
( ordiano R (see Berton et al). 2003;145:1094-101 Association Annual Scientific Sessions 2002: November 17 to
if orliss MS (see Piper et al). 2003;145:1022-9 20, 2002. 2003:145:554-62 (Meetings)
( orra U (see Mezzani et al). 2003;145:1102-7 Desmet W (see Dens et al). 2003;145:404-8 (Progress cardiol.)
( osgrove R (see Taira et al). 2003;145:452-8 Detrano RC (see Khurana et al). 2003:145:724-9
¢ osgrove RS (see Reynolds et al). 2003;145:334-42 Devereux RB (see Oikarinen et al). 2003:145:919-25
( otter G, Cannon CP, McCabe CH, Michowitz Y, Kaluski E, Char- Devereux RB (see Palmieri et al). 2003;145:467-74, 1071-7
lesworth A, Milo O, Bentley J, Blatt A, Krakover R, Zimlichman Dhalla KS (see Rouleau et al). 2003:145:926-32
R, Reisin L, Marmor A, Lewis B, Vered Z, Caspi A, Braunwald E Dhalla NS (see Rouleau et al). 2003:145:926-32
OPUS-TIMI 16 Investigators. Prior peripheral arterial disease Dhanekula LS (see Botkin et al). 2003;145:233-8
and cerebrovascular disease are independent predictors of ad- Di Mario C (see Briguori et al). 2003:145:700-7
verse Outcome in patients with acute coronary syndromes: are Di Pasquale P (see Licata et al). 2003;145:459-66
we doing enough? Results from the Orbofiban in Patients with Di Segni E (see Goldenberg et al). 2003:145:862-7
Unstable Coronary Syndromes-Thrombolysis In Myocardial In- Dickstein K. What did we learn from the OPTIMAAL trial? What can
farction (OPUS-TIMI) 16 study. 2003;145:622-7 we expect from VALIANT? 2003;145:754-7 (Editorial)
ox JL (see Wood et al). 2003;145:806-12 (Progress cardiol.) DiPasquale C (see Pescatello et al). 2003;145:364-70
oyle LC (see Kent et al). 2003;145:e8 Doba N (see Tomiyama et al). 2003:145:e2
ragun KT (see Ting et al). 2003;145:278-84 Domanski M (see Knatterud et al). 2003;145:262-9
rocker CH (see Ting et al). 2003;145:278-84 Donahue MP (see Dery et al). 2003:145:554-62 (Meetings)
rossman DC (see Hauser et al). 2003;145:602-13 Dorian P (see Newman et al). 2003;145:430-7, 841-6
rystal E, Lamy A, Connolly SJ, Kleine P, Hohnloser SH, Semelhago Douglas JS (see Ghazzal et al). 2003:145: 1006-12
L, Abouzhar L, Cybulsky I, Shragge B, Teoh K, Lonn E, Sawchuk Drazner MH, Palmer BF. Hypertonic saline: a novel therapy for
C, Oezaslan F. Left Atrial Appendage Occlusion Study (LAAOS) advanced heart failure? 2003:145:377-9 (Editorial)
a randomized clinical trial of left atrial appendage occlusion Dubaniewicz W (see Gruchaa et al). 2003;145:125-31
during routine coronary artery bypass graft surgery for long- Dukt A (see Mitrovic et al). 2003:145:e14
term stroke prevention. 2003;145:174-8 (Trial design) Duke University Cooperative Cardiovascular Studies (DUCCS) In-
rystal E (see Connolly et al). 2003;145:226-32 vestigators (see Gheorghiade et al). 2003:145:855-7
POPP Investigators (see Newman et al). 2003;145:430-7 Duscha BD (see Keteyian et al). 2003;145:912-18
uffe MS. Impacting the use of the screening electrocardiogram Dzhanashvili AI (see Malinin et al). 2003;145:397-403 (Curriculum
2003;145:936-7 (Editorial) cardiol.)
ummings CC (see Gurbel et al). 2003;145:239-47
ummings G (see Munagala et al). 2003;145:1046-50
usma JT (see Ting et al). 2003;145:278-84
utlip DE (see Mauri et al). 2003;145:847-54
ybulsky I (see Connolly et al). 2003;145:226-32
Eagle KA (see Kim et al). 2003:145:665-9
ybulsky I (see Crystal et al). 2003;145:174-8 (Trial design)
Easley KA (see Rivenes et al). 2003;145:716-23
Eber B (see Auer et al). 2003:145:e9 (Letter)
D Eckman LJ (see Ricciardi et al). 2003:145:522-8
Edmundowicz D (see Marroquin et al). 2003:145:628-35
Dabrowski M (see Mitrovic et al). 2003:;145:e14 Egstrup K (see Moller et al). 2003;145:147-553
Dacey LJ (see Nowicki et al). 2003;145:1058-62 Egstrup K (see Sondergaard et al). 2003;145:e24
Eisenberg MJ (see Simpson et al). 2003;145:438-44 Frelinger AL III (see Furman et al). 2003;145:e6
Eisenberg MS (see Rea and Eisenberg). 2003;145:749-50 (Editorial) French JK, Ramanathan K, Stewart JT, Gao W, Theroux P, White
Ekery DL, Davidoff R, Orlandi QG, Apstein CS, HesselvikJF , Shemin HD. A score predicts failure of reperfusion after fibrinolytic
RJ. Shapira OM. Diastolic dysfunction after coronary artery therapy for acute myocardial infarction. 2003;145:508-14
bypass grafting: a frequent finding of clinical significance not French JK, Van de Water NS, Sutton TM, Lund M, Gao WZ, Mc-
influenced by intravenous calcium. 2003;145:896-902 Dowell J, Liu-Stratton Y, Pohorence J, Szymanski D, Gold-
Elgazi A (see Blum et al). 2003;145:e7 schmidt-Clermont P, White HD, Browett PJ, Cooke G. Potential
Elian D (see Goldenberg et al). 2003;145:862-7 thrombophilic mutations/polymorphisms in patients with no
Elkayam U (see Gheorghiade et al). 2003;145:S51-4 flow-limiting stenosis after myocardial infarction
Engdahl J, Bang A, Lindqvist J, Herlitz J. Time trends in long-term 2003;145:118-24
mortality after out-of-hospital cardiac arrest, 1980 to 1998, and French JK (see Wong et al). 2003;145:95-102
predictors for death. 2003;145:826-33 Frey A (see O'Connor et al). 2003;145:858-9
Epstein AM (see Leape et al). 2003;145:19-26 Fries R (see Unverdorben et al). 2003;145:e17
Erbs S (see Gielen et al). 2003;145:e3 Froelicher V (see Partington et al). 2003;145:139-46
Ertl G (see Bonz et al). 2003;145:693-9 Frykman V, Ayers GM, Darpo B, Rosenqvist M. What characterizes
Escaned J (see Alfonso et al). 2003;145:254-61 episodes of atrial fibrillation requiring cardioversion? Experi-
Eskilsson J (see Tingberg et al). 2003;145:e1 ence from patients with an implantable atrial cardioverter.
Esler A (see Havranek et al). 2003;145:993-8 2003; 145:670-5
Estacio RO (see Havranek et al). 2003;145:993-8 Fujita M, Mizuno K, Ho M, Tsukahara R, Miyamoto A, Miki O, Ishii
Evans MA (see Lapeyre et al). 2003;145:357-63 K, Miwa K. Sarpogrelate treatment reduces restenosis after
Every NR (see Rumsfeld et al). 2003;145:493-9 coronary stenting. 2003;145:e16
Exil V (see Benun et al). 2003;145:424-9 Fung W-H (see Yu et al). 2003;145:e23
Furman MI, Kereiakes DJ, Krueger LA, Mueller MN, Broderick TM,
SchneiderJF , Howard WL, Fox ML, Barnard MR, Frelinger AL II,
Michelson AD. Quantification of abciximab-induced platelet in-
F
hibition is assay dependent: a comparative study in patients
undergoing percutaneous coronary intervention. 2003;145:e6
Fabsitz RR (see Palmieri et al). 2003;145:467-74
Fussl R (see Schneider et al). 2003;145:e4
Fang ZY, Marwick TH. Mechanisms of exercise training in patients
with heart failure. 2003;145:904-11
Farias EF (see Perna et al). 2003;145:e19 (Letter reply)
Farrell KL (see Piper et al). 2003;145:1022-9 G
Fassbender S$ (see Schneider et al). 2003;145:e4
Faulx MD, Wright AT, Hoit BD. Detection of endothelial dysfunc- Gsior M (see Poloski et al). 2003;145:855-61
tion with brachial artery ultrasound scanning. 2003;145:943-51 Gallagher JJ (see Littmann et al). 2003:145:768-78 (Curriculum
(Curriculum cardiol.) cardiol.)
Fearon WF, Yeung AC, Lee DP, Yock PG, Heidenreich PA. Cost- Gao W (see French et al). 2003;145:508-14
effectiveness of measuring fractional flow reserve to guide cor- Gao W (see Wong et al). 2003;145:95-102
onary interventions. 2003;145:882-7 Gao WZ (see French et al). 2003:145:118-24
Feinberg MS, Scheinowitz M, Laron Z. Cardiac dimension and Garcia-Alvarez I (see Mozas et al). 2003:145:999-1005
function in patients with childhood onset growth hormone Garcia P (see Alfonso et al). 2003;145:254-61
deficiency, before and after growth hormone retreatment in Gardin JM (see Munagala et al). 2003;145:1046-50
adult age. 2003:145:549-53 Garratt KN (see Ting et al). 2003:145:278-84
Felker GM, Adams KF Jr, Konstam MA, O'Connor CM, Gheorghiade Gatsonis C (see Leape et al). 2003:145:19-26
M. The problem of decompensated heart failure: nomenclature, Gattis WA (see Gheorghiade et al). 2003;145:S1-2, $51-4, $55-
classification, and risk stratification. 2003;145:518-25 S60-1, SO7-70
Felker GM, O'Connor CM. A bridge for the 21st century in heart Gattis WA (see Jain et al). 2003;145:S83-17
transplantation? 2003;145:198-9 (Editorial) Gattis WA (see O'Connor et al). 2003;145:547-50, $58-9
Fernndez C (see Alfonso et al). 2003:145:254-61 Gattis WA (see Zampino et al). 2003;145:S62-6
Fisher SD (see Benun et al). 2003;145:424-9 Gattone M. Cytomegalovirus seropositivity, infectious burden, and
Flaherty PJ (see Kent et al). 2003;145:e8 coronary artery disease. 2003;145:e10 (Letter reply)
Flosbach CW (see Kleber et al). 2003;145:614-21 Gavazzi A, Ghio S, Scelsi L, Campana C, Klersy C, Serio A, Raineri C,
Fogel MA, Weinberg PM, Haselgrove J. Flow volume asymmetry in Tavazzi L. Response of the right ventricle to acute pulmonary
the right aortic arch in children with magnetic resonance phase vasodilation predicts the outcome in patients with advanced
encoded velocity mapping. 2003;145:154-61 heart failure and pulmonary hypertension. 2003;145:310-16
Follone G (see Licata et al). 2003;145:459-66 Geller NL (see Knatterud et al). 2003;145:262-9
Forder P (see Hague et al). 2003:145:643-51 Gelpi RJ (see Ruiz et al). 2003;145:834-40
Forman SA (see Knatterud et al). 2003:145:262-9 Gent M (see Connolly et al). 2003;145:226-32
Forrester JS (see Knatterud et al). 2003;145:262-9 Gent M (see Newman et al). 2003;145:430-7
Fox ER, Picard MH, Chow C-M, Levine RA, Schwamm L, Kerr Gerschutz GP, Bhatt DL. The Clopidogrel in Unstable Angina to
AJ. Interatrial septal mobility predicts larger shunts across Prevent Recurrent Events (CURE) study: to what extent should
patent foramen ovales: an analysis with transmitral Doppler the results be generalizable? 2003:145:595-601 (Progress car-
scanning. 2003;145:730-6 diol.)
Fox ML (see Furman et al). 2003;145:e6 Gersh BJ (see Kullo and Gersh). 2003;145:941-2 (Editorial)
Francis GS, Tang WHW. 6-Blockers and reverse remodeling: what Gevorkian N (see Gruberg et al). 2003;145:529-34
are the implications? 2003;145:200-2 (Editorial) Ghali JK. Heart failure with preserved systolic function after myo-
Franklin SS (see Wong et al). 2003;145:888-95 cardial infarction: a growing burden? 2003;145:575-8 (Editorial)
Franzosi MG (see Villella et al). 2003:145:475-83 Ghazzal Z, Ashfaq S, Morris DC, DouglasJ S, MarshallJJ , King SB II,
Frazier C, Alexander K. The finer points of race and hypertension. Weintraub WS. Prognostic implication of creatine kinase release
2003; 145:206-8 (Editorial) after elective percutaneous coronary intervention in the pre-
Freedom RM (see Baram et al). 2003;145:1063-70 lib/Illa antagonist era. 2003;145:1006-12
Freimark D (see Goldenberg et al). 2003;145:862-7 Ghazzi MM (see Russell et al). 2003;145:179-86 (Trial design)
Gheorghiade M, Adams KF Jr, Gattis WA, Teerlink JR, Orlandi C aortocoronary saphenous vein graft intervention
O'Connor CM. Surrogate end points in heart failure trials. 2003 2003: 145:529-34
145:S67-70 Gruchaa M, Ciewierz D, Wasag B, Targoski R, Dubaniewicz W,
Gheorghiade M, Gattis WA, Adams KF Jr, Jaffe AS, O’Connor CM Nowak A, Sobiczewski W, Ochman K, Romanowski P, Limon J,
Duke University Cooperative Cardiovascular Studies (DUCCS) Rynkiewicz A. Association of the Sca/ atrial natriuretic peptide
Investigators. Rationale and design of the Pilot Randomized gene polymorphism with nonfatal myocardial infarction and
Study of Nesiritide versus Dobutamine in Heart Failure (PRE- extent of coronary artery disease. 2003;145:125-31
SERVD-HF). 2003; 145:855-7 Grunwald GK (see Rumsfeld et al). 2003;145:493-9
Gheorghiade M, Gattis WA, Barbagelata A, Adams KF Jr, Elkayam U, Gubernikoff G (see Ricciardi et al). 2003;145:522-8
Orlandi C, O'Connor CM, Acute and Chronic Therapeutic Im- Guduguntla V (see Munagala et al). 2003;145:1046-50
pact of a Vasopressin Antagonist in Congestive Heart Failure Guetta V (see Goldenberg et al). 2003;145:862-7
(ACTIV in CHF) Investigators. Rationale and study design for a Gumanovsky M (see Blum et al). 2003;145:e7
multicenter, randomized, double-blind placebo-controlled Guo Y-F, Stein PK. Circadian rhythm in the cardiovascular system
study of the effects of tolvaptan on the acute and chronic chronocardiology. 2003;145:779-86 (Curriculum cardiol.)
outcomes of patients hospitalized with worsening congestive Gupta N (see Brodie et al). 2003;145:708-15
heart failure. 2003;145:S51-4 Gurbel PA, Cummings CC, Bell CR, Alford AB, Meister AF, Sereb-
Gheorghiade M, Gattis WA, Lukas MA, O’Connor CM, IMPACT-HI ruany VL. Onset and extent of platelet inhibition by clopidogrel
Investigators. Rationale and design of the Initiation Manage- loading in patients undergoing elective coronary stenting: the
ment Predischarge: Process for Assessment of Carvedilol Ther Plavix Reduction Of New Thrombus Occurrence (PRONTO)
apy for Heart Failure (IMPACT-HF) study. 2003;145:S60-1 trial. 2003:145:239-47
Gheorghiade M, Gattis WA, O'Connor CM, Adams KF Jr. The man Gurbel PA (see Serebruany et al). 2003;145:636-42
agement of decompensated heart failure resulting in hospital- Gyntelberg F (see Jeppesen et al). 2003;145:103-8
ization: proceedings from an expert meeting to review current
concepts and to define future directions—Introduction. 2003
145:S1-2 H
Gheorghiade M (see Adams et al). 2003;145:834-46
Gheorghiade M (see Felker et al). 2003;145:S18-25 Haddock CK, Poston WSC, Taylor JE, Conard M, Spertus J. Smoking
Gheorghiade M (see Jain et al). 2003;145:S3-17 and health outcomes after percutaneous coronary intervention
Gheorghiade M (see O’Connor et al). 2003;145:847-50, $58-9 2003: 145:652-7
Gheorghiade M (see Zampino et al). 2003;145:S62-6 Hafner G (see Ries et al). 2003;145:737-41
Ghio S$ (see Gavazzi et al). 2003;145:310-16 Hague W, Forder P, Simes J, Hunt D, Tonkin A, LIPID Investigators
Gianetti J, De Caterina R. Prostaglandin E, temporarily decreases Effect of pravastatin on cardiovascular events and mortality in
adhesion molecules. 2003;145:e13 (Letter reply) 1516 women with coronary heart disease: results from the
Giannitsis E (see Bonnemeier et al). 2003; 145:484-92 Long-Term Intervention with Pravastatin in Ischemic Disease
Giannuzzi P (see Mezzani et al). 2003;145:1 102-7 (LIPID) study. 2003;145:643-51
Gibbons RJ (see Lapeyre et al). 2003;145:357-63, 1051-7 Hahalis G (see Alexopoulos et al). 2003;145:542-8
Gibson CM (see Bahit et al). 2003;145: 109-17 HainesJ L (see Hauser et al). 2003;145:602-13
Gielen $, Erbs S$, Linke A, MObius-Winkler $, Schuler G, Hambrecht Halkin A (see Goldenberg et al). 2003;145:862-7
R. Home-based versus hospital-based exercise programs in pa- Halliburton SS (see Klingensmith et al). 2003;145:795-805 (Progress
tients with coronary artery disease: effects on coronary vaso- cardiol.)
motion. 2003:;145:e4 Hambrecht R (see Gielen et al). 2003;145:e3
Gierlotka M (see Poloski et al). 2003;145:855-61 Han RK (see Baram et al). 2003;145:1063-70
Giordano A (see Mezzani et al). 2003;145:1 102-7 Hannan EL, Wu C. Assessing quality and outcomes for percutane
Giorgi LV (see Marso et al). 2003;145:270-7 ous coronary intervention: choosing statistical models, out
GISSI-2 Investigators (see Villella et al). 2003;145:475-83 comes, time periods, and patient populations. 2003;145:571-4
Giubbini R (see Metra et al). 2003;145:292-9 (Editorial)
Gobel FL (see Knatterud et al). 2003;145:262-9 Hansen CJ (see Brodie et al). 2003;145:708-15
Gok R (see Taubert et al). 2003;145:285-91 Hansen MS (see Rouleau et al). 2003;145:926-32
Gold MR (see Newman et al). 2003;145:841-6 Harrington RA (see Hasdai et al). 2003;145:73-9
Goldberg RJ (see Spencer et al). 2003;145:500-7 Hartmann F (see Bonnemeier et al). 2003;145:484-92
Goldberg S$ (see Kandzari et al). 2003;145:868-74 Hasdai D. Endothelium-independent coronary microvascular func
Goldenberg I, Matetzky $, Halkin A, Roth A, Di Segni E, Freimark D tion: all vessels are not created equally. 2003;145:567-8 (Edito-
Elian D, Agranat O, Zahav YH, Guetta V, Hod H. Primary angio rial)
plasty with routine stenting compared with thrombolytic ther Hasdai D, Topol EJ, Kilaru R, Battler A, Harrington RA, Vahanian A,
apy in elderly patients with acute myocardial infarction. 2003 Ohman EM, Granger CB, Van de Werf F, Simoons ML, O’Connor
145:862-7 CM, Holmes DR Jr. Frequency, patient characteristics, and out
Goldman C (see Rajagopalan et al). 2003;145:1114-18 comes of mild-to-moderate heart failure complicating ST-seg
Goldschmidt-Clermont P (see French et al). 2003;145:118-24 ment elevation acute myocardial infarction: lessons from 4 in-
Gore JM (see Spencer et al). 2003;145:500-7 ternational fibrinolytic therapy trials. 2003;145:73-9
Goss JR (see Maynard et al). 2003;145:658-64 Haselgrove J (see Fogel et al). 2003;145:154-61
Gracey HM (see Menown et al). 2003;145:986-92 Hassan K (see Casscells et al). 2003;145:813-20
Granger CB (see Al-Khatib et al). 2003;145:515-21 Hassan MR (see Casscells et al). 2003;145:813-20
Granger CB (see Batchelor et al). 2003;145:349-55 Hauser ER, Mooser V, Crossman DC, HainesJ L, Jones CH, Winkel-
Granger CB (see Hasdai et al). 2003:145 3-9 mann BR, Schmidt S$, Scott WK, Roses AD, Pericak-Vance MA,
Granger CB (see Hauser et al). 2003;145:602-13 Granger CB, Kraus WE. Design of the Genetics of Early Onset
Granger CB (see Serebruany et al). 2003;145:636-42 Cardiovascular Disease (GENECARD) study. 2003;145:602-13
Green HJ (see Keteyian et al). 2003;145:912-18 Havranek EP, Esler A, Estacio RO, Mehler PS, Schrier RW. Differen-
Grossman PM (see Mehta et al). 2003;145:1078-85 tial effects of antihypertensive agents on electrocardiographic
Gruberg L, Weissman NJ, Pichard AD, Waksman R, Kent KM, Satler voltage: results from the Appropriate Blood Pressure Control in
LF, Suddath WO, Pinnow EE, Gevorkian N, Lindsay J Jr. Impact Diabetes (ABCD) trial. 2003;145:993-8
of renal function on morbidity and mortality after percutaneous Hearne MJ (see Piper et al). 2003;145:1022-9
1124 Author index
Heidenreich PA (see Fearon et al). 2003;145:882-7 Iskandrian AE (see Patel and Iskandrian). 2003;145:952-61 (Curric-
Hein HO (see Jeppesen et al). 2003;145:103-8 ulum cardiol.)
Held S$ (see Bonz et al). 2003;145:693-9 Isojima K (see Nishioka et al). 2003;145:162-8
Hellermann JP, Jacobsen SJ, Reeder GS, Lopez-Jimenez F, Weston Israeli P (see Blum et al). 2003;145:e7
SA, Roger VL. Heart failure after myocardial infarction: preva-
lence of preserved left ventricular systolic function in the com-
munity. 2003;145:742-8 J
Helqvist S$ (see Jorgensen et al). 2003;145:e5
Hennen B (see Unverdorben et al). 2003;145:e17 Jabbour S$ (see Spencer et al). 2003;145:500-7
Herd JA (see Knatierud et al). 2003;145:262-9 Jabs A (see Bauriedel et al). 2003;145:343-8
Herlitz J (see Engdahl et al). 2003;145:826-33 Jackson JD, Muhlestein JB, Bunch TJ, Bair TL, Horne BD, Madsen
Hermes R (see Ruiz et al). 2003;145:834-40 TE, Lappé JM, Anderson JL, Intermountain Heart Collaborative
Hernandez AF (see Dery et al). 2003;145:554-62 (Meetings) Study (IHCS) Group. B-Blockers reduce the incidence of clinical
Hernndez R (see Alfonso et al). 2003;145:254-61 restenosis: prospective study of 4840 patients undergoing per-
Herrington DM (see Abdelhamed et al). 2003;145:e15 cutaneous coronary revascularization. 2003;145:875-81
Hesselvik JF (see Ekery et al). 2003;145:896-902 Jacobs M (see Bonz et al). 2003;145:693-9
Hettleman BD (see Piper et al). 2003;145:1022-9 Jacobs MJ (see Wong et al). 2003;145:888-95
Hickey A (see Knatterud et al). 2003;145:262-9 Jacobsen SJ (see Hellermann et al). 2003;145:742-8
Hikita H (see Nishioka et al). 2003;145:162-8 Jaffe AS (see Gheorghiade et al). 2003;145:855-7
Hill JA (see Aranda et al). 2003;145:324-9 Jain P, Massie BM, Gattis WA, Klein L, Gheorghiade M. Current
Hillis GS, Taggart P, Hillis L, Zhao N, Dalsey WC, Mangione A medical treatment for the exacerbation of chronic heart failure
Biochemical and clinical predictors of long-term outcome in resulting in hospitalization. 2003;145:S3-17
patients with nonspecific chest pain and nondiagnostic electro- Jani K (see Mehta et al). 2003;145:821-5
cardiograms. 2003; 145:88-94 Jantus E (see Perna et al). 2003;145:e19 (Letter reply)
Hillis L (see Hillis et al). 2003;145:88-94 Jenkins KJ (see Rivenes et al). 2003;145:716-23
Hintereder G (see Ries et al). 2003;145:737-41 Jensen GVH (see Jorgensen et al). 2003;145:e5
Hirsch AT (see Rajagopalan et al). 2003;145:1114-18 Jeong Y-H (see Song et al). 2003;145:371-6
Hlatky MA (see Melsop et al). 2003;145:36-41 Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. High triglycerides/
Ho KKL (see Mauri et al). 2003;145:847-54 low high-density lipoprotein cholesterol, ischemic electrocar-
Ho KKL (see Reynolds et al). 2003;145:334-42 diogram changes, and risk of ischemic heart disease. 2603;145:
Ho M (see Fujita et al). 2003;145:e16 103-8
Hod H (see Goldenberg et al). 2003;145:862-7 Jern S (see Oikarinen et al). 2003;145:919-25
Hohnloser SH (see Crystal et al). 2003;145:174-8 (Trial design) Jimenez JJ (see Bernal-Mizrachi et al). 2003;145:962-70 (Progress
Hoit BD (see Faulx et al). 2003;145:943-51 (Curriculum cardiol.) cardiol.)
Holmes DR Jr, Danoff TM. Tranilast for restenosis: efficacious or Joaquim MR (see Maia et al). 2003;145:e27
not? 2003;145:e22 (Letter reply) Johnson L (see Newman et al). 2003;145:841-6
Holmes DR Jr (see Best and Holmes). 2003;145:383-6 (Editorial) Johnson RG (see Reynolds et al). 2003;145:334-42
Holmes DR Jr (see Hasdai et al). 2003;145:73-9 Johnson WL (see Marso et al). 2003;145:270-7
Holmes DR (see Ting et al). 2003;145:278-84 Johnstone DE (see Wood et al). 2003;145:806-12 (Progress cardiol.)
Holubkov R (see Marroquin et al). 2003;145:628-35 Jones CH (see Hauser et al). 2003;145:602-13
Hong M-K (see Song et al). 2003;145:371-6 Jorgensen B, Thaulow E. Effects of amlodipine on ischemia after
Hoogwerf BJ (see Knatterud et al). 2003;145:262-9 percutaneous transluminal coronary angioplasty: secondary re-
Hopkins PN (see Palmieri et al). 2003;145:107 1-7 sults of the Coronary Angioplasty Amlodipine Restenosis (CA-
Hopp HW (see Schneider et al). 2003;145:e4 PARES) study. 2003;145:1030-5
Horne BD (see Jackson et al). 2003;145:875-81 Jorgensen E, Kelbek H, Helqvist S, Jensen GVH, Saunamaki K,
Horstman LL (see Bernal-Mizrachi et al). 2003;145:962-70 (Progress Kastrup J, Madsen JK, Klovgaard L, Thuesen L, Villadsen A, van
cardiol.) Weert AWM, Reiber JHC. Low restenosis rate of the NIK coro-
Houlihan RJ (see Ting et al). 2003;145:278-84 nary stent: results of the Danish multicenter stent study (DAN-
Howard BV (see Khurana et al). 2003;145:724-9 STENT)—a randomized trial comparing a first-generation stent
Howard BV (see Palmieri et al). 2003;145:467-74 with a second-generation stent. 2003;145:e5
Howard G (see Ahmed et al). 2003;145: 1086-93 Jy W (Gee Bernal-Mizrachi et al). 2003;145:962-70 (Progress cardiol.)
Howard WL (see Furman et al). 2003;145:e6
Hsia J (see Khurana et al). 20043;145:724-9
Huber KC (see Marso et al). 2003;145:270-7
K
Hunninghake DB (see Knatterud et al). 2003;145:262-9
Hunt D (see Hague et al). 2003;145:643-51
Kaluski E (see Cotter et al). 2003;145:622-7
Hyder M (see Spencer et al). 2003;145:500-7
Kampmann C (see Ries et al). 2003;145:737-41
Kandzari DE, Goldberg $, Schwartz RS, Chazin-Caldie M, Sketch MH
Jr, SCORES SVG Registry Investigators. Clinical and angio-
graphic efficacy of a self-expanding nitinol stent in saphenous
vein graft atherosclerotic disease: the Stent Comparative Reste-
Ibrahim H (see Unverdorben et al). 2003;145:e17 nosis (SCORES) Saphenous Vein Graft Registry
Ikeda U (see Matsui et al). 2003:145:330-3 2003; 145:868-74
IMPACT-HF Investigators (see Gheorghiade et al). 2003;145:S60-1 Kandzari DE, TchengJ E. Double negatives. 2003:145:9-12 (Editori-
Indridason OS, Coffman CJ, Oddone EZ. Is specialty care associated al)
with improved survival of patients with congestive heart fail- Kang D-H (see Song et al). 2003;145:371-6
ure? 2003;145:300-9 Kaplan S (see Rivenes et al). 2003;145:716-23
Intermountain Heart Collaborative Study (IHCS) Group (see Jack- Kasravi B (see Munagala et al). 2003;145:1046-50
son et al). 2003;145:875-81 Kastrup J (see Jorgensen et al). 2003;145:e5
Irvine J (see Newman et al). 2003;145:430-7 Katsushika S$ (see Nishioka et al). 2003;145:162-8
Ishii K (see Fujita et al). 2003;145:e16 Katus HA (see Bonnemeier et al). 2003;145:484-92
Kay JD (see Dery et al). 2003;145:554-62 (Meetings) Kondys M (see Poloski et al). 2003;145:855-61
Kelbexk H (see Jorgensen et al). 2003;145:e5 Kong DF (see Liao and Kong). 2003;145:187-9 (Editorial)
Kelder JC (see ten Berg et al). 2003;145:58-65 Kong S-L (see Yu et al). 2003;145:e23
Kellett MA Jr (see Piper et al). 2003;145:1022-9 Konstam MA (see Felker et al). 2003;145:S18-25
Kent KM (see Gruberg et al). 2003;145:529-34 Konz KH (see Schneider et al). 2003;145:e4
Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Taylor AJ. Effect of Koppenhagen K (see Kleber et al). 2003;145:614-21
atorvastatin and pravastatin on serum C-reactive protein. 2003 Krakover R (see Cotter et al). 2003;145:622-7
145:e8 Kraus WE (see Hauser et al). 2003;145:602-13
Kereiakes DJ (see Furman et al). 2003;145:e6 Kraus WE (see Keteyian et al). 2003;145:912-18
Keren A (see Almagor et al). 2003;145:248-53 Krone RJ (see Kizer et al). 2003;145:683-92
Kerns WP Il (see Littmann et al). 2003;145:768-78 (Curriculum Krueger L (see Pescatello et al). 2003;145:364-70
cardiol.) Krueger LA (see Firman et al). 2003:145:¢6
Kerr AJ (see Fox et al). 2003;145:730-6 Kullo IJ, Gersh BJ. Markers of inflammation and thrombosis: clues
Kerr C (see Newman et al). 2003;145:430-7 to plaque instability? 2003;145:941-2 (Editorial)
Kervanciolu C (see Akyiirek et al). 2003;145:66-72 Kumbasar D (see Akytirek et al). 2003;145:66-72
Keteyian SJ, Duscha BD, Brawner CA, Green HJ, Marks CRC, Scha- Kuntz RE (see Mauri et al). 2003;145:847-54
chat FH, Annex BH, Kraus WE. Differential effects of exercise Kurita A (see Nishioka et al). 2003;145:162-8
training in men and women with chronic heart failure. 2003 Kurowski V (see Bonnemeier et al). 2004;145:484-92
145:912-18
Kezouh A (see Brassard et al). 2003;145:e25
Khan IA. Atria! stunning: determinants and cellular mechanisms L
2003; 145:787-94 (Progress cardiol.)
Khan IA (see Mehta et al). 2003;145:821-5 ager RA (see Reynolds et al). 2003:145:334-42
Khan MN (see Rivenes et al). 2003;145:716-23 ahey SJ (see Nowicki et al). 2003;145:1058-62
Al-Khatib SM, Stebbins AL, Califf RM, Lee KL, Granger CB, White ai WW (see Rivenes et al). 2003;145:716-23
HD, Armstrong PW, Topol EJ, Ohman EM. Sustained ventricular amy A (see Connolly et al). 2003;145:226-32
arrhythmias and mortality among patients with acute myocar amy A (see Crystal et al). 2003;145:174-8 (Trial design)
dial infarction: results from the GUSTO-III trial ang N (see Blum et al). 2003;145:e7
2003;145:515-21 apeyre AC Ill, Evans MA, Christian TF, Daley JR, Gibbons RJ. Com-
Khurana C, Rosenbaum CG, Howard BV, Adams-Campbell LL, De- parison of the predischarge exercise thallium-201 perfusion
trano RC, Klouj A, Hsia J. Coronary artery calcification in black defect after myocardial infarction with myocardium at risk mea-
women and white women. 2003;145:724-9 sured during acute infarction with technetium-99m sestamibi
Kiefe Cl (see Ahmed et al). 2003;145: 1086-93 imaging. 2003;145:357-63
Kilaru R (see Hasdai et al). 2003;145:73-9 apeyre AC Ill, St Gibson W, Bashore TM, Gibbons RJ. Quantitative
Kim J-J (see Song et al). 2003;145:3716 regional wall motion analysis with early contrast ventriculogra
Kim MH, Decena BF, Bruckman D, Eagle KA. Use patterns of phy for the assessment of myocardium at risk in acute myocar-
low-molecular weight heparin and the impact on length of stay dial infarction. 2003:145:1051-7
in patients hospitalized for atrial fibrillation. 2003; 145:665-9 Lapointe N (see Rouleau et al). 2003;145:926-32
Kimmel SE (see Kizer et al). 2003;145:683-92 Lappe JM (see Jackson et al). 2003;145:875-81
King SB III (see Ghazzal et al). 2003;145:1006-12 Lapuerta P (see Wong et al). 2003;145:888-95
Kiowski W (see Mitrovic et al). 2003;145:e14 Laron Z (see Feinberg et al). 2003:145:549-53
Kirkeeide RL (see Casscells et al). 2003;145:813-20 Laskey WK (see Kizer et al). 2003;145:683-92
Kirshenbaum JM (see Resnic et al). 2003;145:42-6 Laster SB (see Marso et al). 2003;145:270-7
Kitzman DW (see Palmieri et al). 2003;145:1071-7 Lau C (see Newman et al). 2003;145:430-7
Kizer JR, Berlin JA, Laskey WK, Schwartz JS, Sauer WH, Krone RJ Leach D (see Aranda et al). 2003;145:324-9
Kimmel SE. Limitations of current risk-adjustment models in the Leape LL, Weissman JS, Schneider EC, Piana RN, Gatsonis C, Ep-
era of coronary stenting. 2003;145:683-92 stein AM. Adherence to practice guidelines: the role of specialty
Kjelsberg MA (see Ting et al). 2003;145:278-84 society guidelines. 2003;145:19-26
Kleber F-X, Witt C, Vogel G, Koppenhagen K, Schomaker U, Flos- Leavitt B (see Nowicki et al). 2003;145:1058-62
bach CW, THE-PRINCE Study Group. Randomized comparison Lederman RJ (see Rajagopalan et al). 2003;145:1114-18
of enoxaparin with unfractionated heparin for the prevention of Lee C-W (see Song et al). 2003:145:371-6
venous thromboembolism in medical patients with heart failure Lee DP (see Fearon et al). 2003;145:882-7
or severe respiratory disease. 2003;145:614-21 Lee KL (see Al-Khatib et al). 2003;145:515-21
Klein B (see Taubert et al). 2003;145:285-91 Lee MKY (see Resnic et al). 2003;145:42-6
Klein L (see Jain et al). 2003;145:83-17 Lekston A (see Poloski et al). 2003;145:855-61
Kleine P (see Crystal et al). 2003;145:174-8 (Trial design) Lengenfelder B (see Bonz et al). 2003;145:693-9
Klersy C (see Gavazzi et al). 2003;145:310-16 Lenz K (see Mitrovic et al). 2003:;145:e14
Klingensmith JD, Schoenhagen P, Tajaddini A, Halliburton SS, Lessard D (see Spencer et al). 2003;145:500-7
fuzcu EM, Nissen SE, Vince DG. Automated three-dimensional Levine RA (see Fox et al). 2003;145:730-6
assessment of coronary artery anatomy with intravascular ultra- Lewis B (see Cotter et al). 2003;145:622-7
sound scanning. 2003;145:795-805 (Progress cardiol.) Lewis MR (see Palmieri et al). 2003;145:467-74
Klouj A (see Khurana et al). 2003;145:724-9 Liao L, Kong DF. Angiographic changes in vein grafts: stable surro-
Klovgaard L (see Jorgensen et al). 2003;145:e5 gate or seductive siren? 2003;145:187-9 (Editorial)
Knatterud GL, White C, Geller NL, Campeau L, Forman SA, Doman- Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A,
ski M, ForresterJS , Gobel FL, Herd JA, Hickey A, Hoogwerf BJ, Follone G, Argano C, Tuttolomondo A, Paterna S. Effects of
Hunninghake DB, Terrin ML, Rosenberg Y, Post CABG Investi- high-dose furosemide and small-volume hypertonic saline solu-
gators. Angiographic changes in saphenous vein grafts are pre- tion infusion in comparison with a high dose of furosemide as
dictors of clinical outcomes. 2003;145:262-9 bolus in refractory congestive heart failure: long-term effects
Knight JD (see Batchelor et al). 2003;145:349-55 2003: 145:459-66
Kober L (see Moller et al). 2003;145:147-53 LIFE Study Investigators (see Oikarinen et al). 2003;145:919-25
Koehler H (see Unverdorben et al). 2003;145:e17 Liistro F (see Briguori et al). 2003;145:700-7
Limon J (see Gruchaa et al). 2003;145:125-31 Massie BM (see Jain et al). 2003;145:S3-17
Lin H (see Yu et al). 2003;145:e23 Mata P (see Mozas et al). 2003;145:999-1005
Lindqvist J (see Engdahl et al). 2003;145:826-33 Matetzky S (see Goldenberg et al). 2003;145:862-7
Lindsay J Jr (see Gruberg et al). 2003;145:529-34 Mathew JP (see Booth et al). 2003;145:1 108-13
Linke A (see Gielen et al). 2003;145:e3 Mathew TP (see Menown et al). 2003:145:986-92
LIPID Investigators (see Hague et al). 2003;145:643-51 Mathur VS (see Adams et al). 2003;145:S34-46
Lipshultz SE (see Benun et al). 2003;145:424-9 Matsui K, Ikeda U, Murakami Y, Yoshioka T, Shimada K. Intrave-
Lipshultz SE (see Rivenes et al). 2003;145:716-23 nous prostaglandin El reduces monocyte chemoattractant pro-
L'Italien GJ (see Wong et al). 2003;145:888-95 tein-1 levels in peripheral arterial obstructive disease. 2003:145
Littmann L, Monroe MH, Kerns WP II, Svenson RH, GallagheJrJ . 330-3
Brugada syndrome and “Brugada sign”: clinical spectrum with a Matsumori A (see Sato et al). 2003;145:e18 (Letter)
guide for the clinician. 2003;145:768-78 (Curriculum cardiol.) Mauri L, Reisman M, Buchbinder M, Popma JJ, Sharma SK, Cutlip
Liu-Stratton Y (see French et al). 2003;145:118-24 DE, Ho KKL, Prpic R, Zimetbaum PJ, Kuntz RE. Comparison of
Longaker RA (see Stoddard et al). 2003;145:676-82 rotational atherectomy with conventional balloon angioplasty
Lonn E (see Crystal et al). 2003;145:174-8 (Trial design) in the prevention of restenosis of small coronary arteries: results
Lopez-Jimenez F (see Hellermann et al). 2003;145:742-8 of the Dilatation vs Ablation Revascularization Trial Targeting
Lopez LM (see Aranda et al). 2003;145:324-9 Restenosis (DART). 2003;145:847-54
Liideritz B (see Bauriedel et al). 2003;145:343-8 Mauro LM (see Bernal-Mizrachi et al). 2003:145:962-70 (Progress
Lukas MA (see Gheorghiade et al). 2003;145:S60-1 cardiol.)
Lund M (see French et al). 2003;145:118-24 Maynard C, Goss JR, Malenka DJ, Reisman M. Adjusting for patient
Lupovitz S (see Blum et al). 2003;145:e7 differences in predicting hospital mortality for percutaneous
Lytle BL (see Pasquali et al). 2003;145:445-51 coronary interventions in the Clinical Outcomes Assessment
Program. 2003;145:658-64
Mazeika P, Prasad N, Bui S, Seidelin PH. Predictors of angiographic
M restenosis after coronary intervention in patients with diabetes
mellitus. 2003;145:1013-21
Macaya C (see Alfonso et al). 2003;145:254-61 McCabe CH (see Bahit et al). 2003:145:109-17
Macin SM (see Perna et al). 2003;145:e19 (Letter reply) McCabe CH (see Cotter et al). 2003:145:622-7
Madjid M (see Casscells et al). 2003;145:813-20 McCallister BD (see Marso et al). 2003:145:270-7
Madsen JK (see Jorgensen et al). 2003;145:e5 McCants CB (see Booth et al). 2003;145:1108-13
Madsen TE (see Jackson et al). 2003;145:875-8! McCrindle BW (see Baram et al). 2003;145:1063-70
Maggioni AP (see Villella et al). 2003;145:475-83 McDowell J (see French et al). 2003;145:118-24
Magid DJ (see Rumsfeld et al). 2003;145:493-9 McGrath PD (see Piper et al). 2003;145:1022-9
Maia LN, Nicolau JC, Vitola JV, Santos M, Brandi JM, Joaquim MR, McGuire DK (see Abedin and McGuire). 2003;145:195-7 (Editorial)
Baggi JM Jr, Cordeiro JA, de Godoy MF. Prospective evaluation McKellar J (see Berry et al). 2003;145:1036-45
comparing the effects of enalapril and losartan in left ventricular Meckes CL (see Pescatello et al). 2003:145:364-70
remodeling after acute myocardial infarction. 2003;145:e27 Mehler PS (see Havranek et al). 2003;145:993-8
Malenka DJ (see Maynard et al). 2003;145:658-64 Mehta NJ, Jani K, Khan IA. Clinical usefulness and prognostic value
Malenka DJ (see Piper et al). 2003;145:1022-9 of elevated cardiac troponin I levels in acute pulmonary embo-
Mali WPThM (see Bloemenkamp et al). 2003;145:409-17 (Progress lism. 2003;145:821-5
cardiol.) Mehta RH, Supiano MA, Oral H, Grossman PM, Montgomery DS,
Malinin Al, O'Connor CM, Dzhanashvili Al, Sane DC, Serebruany Smith MJ, Starling MR. Compared with control subjects, the
VL. Platelet activation in patients with congestive heart failure: systemic sympathetic nervous system is activated in patients
do we have enough evidence to consider clopidogrel? 2003; with mitral regurgitation. 2003:145:1078-85
145:397-403 (Curriculum cardiol.) Meister AF (see Gurbel et al). 2003:145:239-47
Malinin Al (see Serebruany et al). 2003;145:636-42 Melsop KA, Boothroyd DB, Hlatky MA. Quality of life and time
Malkin CJ} (see Pugh et al). 2003;145:e11 (Letter) trade-off utility measures in patients with coronary artery dis-
Manca C (see Metra et al). 2003;145:292-9 ease. 2003:145:36-41
Mangione A (see Hillis et al). 2003;145:88-94 Meltzer CC (see Marroquin et al). 2003;145:628-35
Maresh CM (see Pescatello et al). 2003;145:364-70 Mendelsohn FO (see Rajagopalan et al). 2003;145:1114-18
Mark DB (see Batchelor et al). 2003;145:349-55 Menown IBA, Mathew TP, Gracey HM, Nesbitt GS, Murray P, Young
Marks CRC (see Keteyian et al). 2003;145:912-18 IS, Adgey AAJ. Prediction of Recurrent Events by D-dimer and
Marks DS (see Mitrovic et al). 2003;145:e14 Inflammatory markers in patients with normal Cardiac Tropo-
Markwood TT (see Kent et al). 2003;145:e8 nin I (PREDICT) study. 2003;145:986-92
Marmor A (see Cotter et al). 2003;145:622-7 Merry H (see Wood et al). 2003;145:806-12 (Progress cardiol.)
Marroquin OC, Holubkov R, Edmundowicz D, Rickens C, Pohost G, Messere C (see Benun et al). 2003:145:424-9
Buchthal S, Pepine CJ, Sopko G, Sembrat RC, Meltzer CC, Reis Metra M, Nodari S, Parrinello G, Giubbini R, Manca C, Dei Cas L
SE. Heterogeneity of microvascular dysfunction in women with Marked improvement in left ventricular ejection fraction during
chest pain not attributable to coronary artery disease: implica- long-term B-blockade in patients with chronic heart failure
tions for clinical practice. 2003;145:628-35 clinical correlates and prognostic significance. 2003:145:292-9
Marshall JJ (see Ghazzal et al). 2003;145: 1006-12 Meyer J (see Ries et al). 2003;145:737-41
Marso SP, Giorgi LV, Johnson WL, Huber KC, Laster SB, Shelton CJ, Mezzani A, Corra U, Bosimini E, Giordano A, Giannuzzi P. Contri-
McCallister BD, Coen MM, Rutherford BD. Diabetes mellitus is bution of peak respiratory exchange ratio to peak VO2 prog-
associated with a shift in the temporal risk profile of inhospital nostic reliability in patients with chronic heart failure and se-
death after percutaneous coronary intervention: an analysis of verely reduced exercise capacity. 2003;145:1102-7
25,223 patients over 20 years. 2003;145:270-7 Michelson AD (see Furman et al). 2003:145:e6
Marwick TH (see Fang and Marwick). 2003;145:904-11 Michowitz Y (see Cotter et al). 2003;145:622-7
Marz W (see Taubert et al). 2003;145:285-91 Miki O (see Fujita et al). 2003:145:e16
Massey KD (see Russell et al). 2003;145:179-86 (Trial design) Milo O (see Cotter et al). 2003;145:622-7
Massie BM, Ansari MN. Specialty care for heart failure: does it Miric M (see Mitrovic et al). 2003;145:e14
improve outcomes? 2003;145:209-13 (Editorial) Mitani H (see Nishioka et al). 2003;145:162-8
Mitrovic V, Willenbrock R, Miric M, Seferovic P, Spinar J, Dab- Nissen SE (see Klingensmith et al). 2003;145:795-805 (Progress
rowski M, Kiowski W, Marks DS, Alegria E, Dukt A, Lenz K cardiol.)
Arens HA. Acute and 3-month treatment effects of candesartan Nodari $ (see Metra et al). 2004:145:292-9
cilexetil on hemodynamics, neurohormones, and clinical symp- Northern New England Cardiovascular Disease Study Group (see
toms in patients with congestive heart failure. 2003;145:e14 Piper et al). 2003;145:1022-9
Miwa K (see Fujita et al). 2003;145:e16 Nowak A (see Gruchaa et al). 2003;145:125-31
Miyamoto A (see Fujita et al). 2003:145:e16 Nowicki ER, Weintraub RW, Birkmever NJO, Sanders JH, Dacey L}
Mizuno K (see Fujita et al). 2003;145:e16 Lahey SJ, Leavitt B, Clough RA, Quinn RD, O'ConnorG T. Mitral
MObius-Winkler S$ (see Gielen et al). 2003;145:e3 valve repair and replacement in northern New England. 2003
Mohler E Ill (see Rajagopalan et al). 2003;145:1114-18 145: 10584
Moliterno DJ, Penn MS. Angioplasty, inflammation, and antiplatelet Nykanen DG (see Baram et al
agents. 2003;145:563-6 (Editorial) NyvaO d(s ee Moller et al). 2004
Moliterno DJ (see Quinn and Moliterno). 2003;145:203-5 (Editorial)
Moller JE, Egstrup K, Kober L, Poulsen SH, Nyvad O, Torp-Pedersen
C. Prognostic importance of systolic and diastolic function after
acute myocardial infarction. 2003;145:147-53
Moller JE (see Sondergaard et al). 2003;145:e24
Iberman A (see Palmieri et al). 2004;:145: 1071-7
Monroe MH (see Littmann et al). 2003;145:768-78 (Curriculum
) Brien B (see Connolly et al). 20043:145:226-42
cardiol.)
ychman K (see Gruchaa et al). 2003:145:125-31
Monroe VS Jr (see Aranda et al). 2003;145:324-9
Connor CM. Gattis WA. Adams KF Jr. Shah MR. Frey A. Gheo-
Montgomery DS (see Mehta et al). 2003;145:1078-85
rghiade M,. RITZ-4 Investigators. Tezosentan in patients with
Montorfano M (see Briguori et al). 2003;145:700-7
acute heart failure and acute coronary syndromes: design of the
Moodie DS (see Rivenes et al). 2003;145:716-23
fourth Randomized Intravenous Tezosentan Study (RITZ-4)
Mooser V (see Hauser et al). 2003;145:602-13 2003:145:S58-9
Morioka D. Tranilast for restenosis: efficacious or not? 2003;145
Connor CM, Gattis WA, Teerlink JR, Adams KF Jr, Gheorghiade
e20 (Letter)
M. Design considerations and proposed template for clinical
Morris DC (see Ghazzal et al). 2003;145: 1006-12
trials in hospitalized patients with decompensated chronic
Morrow DA, de Lemos JA. Assessing the success of fibrinolysis: can
heart failure. 2003;145:847-50
we let the interventionalist rest? 2003;145:380-2 (Editorial)
Connor CM (see Bourque et al). 2003;145:758-67 (Curriculum
Moyna NM (see Pescatello et al). 2003;145:364-70
cardiol.)
Mozas P, Castillo $, Reyes G, Tejedor D, Civeira F, Garcia-Alvarez |
Connor CM (see Felker and O'Connor). 2004;145:198-9 (Editorial)
Puzo J, Cenarro A, Alonso R, Mata P, Pocovi M, Spanish group
Connor CM (see Felker et al). 2003;145:S18-25
FH. Apolipoprotein E genotype is not associated with cardio-
Connor CM (see Gheorghiade et al). 2004:145:S1-2, S51-4, 855
vascular disease in heterozygous subjects with familial hyper S60-1. S67-70
cholesterolemia. 2003;145:999-1005
¥ Connor CM (see Hasdai et al). 20043:145:73-9
Mueller MN (see Furman et al). 2003;145:e6
Connor CM (see Malinin et al). 2003:145:397-403 (Curriculum
Muhlestein JB (see Jackson et al). 2003;145:875-81
cardiol. )
Munagala VK, Guduguntla V, Kasravi B, Cummings G, Gardin JM
Connor CM (see Zampino et al). 2003:145:862-6
Use of atropine in patients with chronotropic incompetence y¥ Connor GT (see Nowicki et al)1 . 2003:145: 1058-62
and poor exercise capacity during treadmill stress testing. 2003
Connor GT (see Piper et al). 2003;145:1022-9
145:1046-50
’\ddone EZ (see Indridason et al). 2003:145:300-9
Muncy DB (see Brodie et al). 2003;145:708-15
yezaslan F (see Crystal et al). 2003;145:174-8 (Trial design)
Murakami Y (see Matsui et al). 2003;145:330-3 guogho A (see Palumbo et al). 2003:145:e12 (Letter)
Murphy SA (see Bahit et al). 2003;145:109-17 Yhlin H (see Tingberg et al). 2003;145:e1
Murray P (see Menown et al). 2003;145:980-92
Jhman EM. ! rtot litor. 2003;145:¢€26
Myers J (see Partington et al). 2003;145:139-46
YJnman EM (see Al-Khatib et al). 2003;145:515-21
Ynman EM (see Hasdai et al). 2003:145:73-9
Ynno-Machado L (see Resnic et al). 2003:145:42-6
N Yhsuzu F (see Nishioka et al). 20043:145:162-8
Yhtomi S$ (see Nishioka et al). 2003;145:162-8
Nagai T (see Nishioka et al). 2003;145:162-8 jikarinen L, Nieminen MS, Toivonen L, Viitasalo M, Wachtell K,
Naghavi M (see Casscells et al). 2003;145:813-20 Papademetriou V, Jern S$, Dahlof B, Devereux RB, Okin PM, LIFE
Neil N (see Reynolds et al). 2003:145:334-42 Study Investigators. Relation of QT interval and QT dispersion
Nesbitt GS (see Menown et al). 2003;145:986-92 to regression of echocardiographic and electrocardiographic
Newman D, Lau C, Tang ASL, Irvine J, Paquette M, Woodend K left ventricular hypertrophy in hypertensive patients: the Losar
Dorian P, Gent M, Kerr C, Connolly $], CTOPP Investigators tan Intervention For Endpoint Reduction (LIFE) study. 2003;
Effect of pacing mode on health-related quality of life in the 145:919-25
Canadian Trial of Physiologic Pacing. 2003; 145:430-7 Ikin PM (see Oikarinen et al). 2004;145:919 ) 5
Newman DM, Dorian P, Paquette M, Sulke N, Gold MR, Schwartz lin J (see Rajagopalan et al). 2003;145:1114-18
man DS, Schaaf K, Wood K, Johnson L, Worldwide Jewel AI Yishansky B (see Botkin et al). 2003;145:233-8
AF-Only Investigators. Effect of an implantable cardioverter de )’Mears JR (see Piper et al). 2003;145:1022-9
fibrillator with atrial detection and shock therapies on patient- Y)PUS-TIMI 16 Investigators (see Cotter et al). 2003;145:622-7
perceived, health-related quality of life. 2003;145:841-6 ral D (see Akyurek et al). 2003:145:06-72
Newman MF (see Booth et al). 2003;145:1108-13 Yral H (see Mehta et al). 2003;145:1078-85
Nicolau JC (see Maia et al). 2003;145:e27 yrav EJ (see Benun et al). 2003:145:424-9
Nieminen MS (see Oikarinen et al). 2003;145:919-25 rlandi C (see Gheorghiade et al). 2003:145:S851-4, $67-70
Nishioka T, Mitani H, Uehata A, Hikita H, Nagai T, Katsushika S, rlandi QG (see Ekery et al). 2003:145:896-902
Takase B, Isojima K, Ohsuzu F, Kurita A, Ohtomi S, Siegel RJ Irnato J (see Welsh et al). 2003:145:1-8 (Progress cardiol.)
Effect of infarcted myocardium on diagnostic accuracy of exer- )ropeza ES, Cadena CN. New phenotype of familial dilated cardio-
cise echocardiography for detecting noninfarct-related coro- myopathy and conduction disorders. 2003;145:317-23
nary artery lesions. 2003;145:162-8 ) Shea S (see Reddan et al). 2003:145:586-94 (Curriculum cardiol.)
P Piana R (see Resnic et al). 2003;145:42-6
Piana RN (see Leape et al). 2003;145:19-26
Packer M (see Rouleau et al). 2003;145:926-32 Pianca S (see Berton et al). 2003;145:1094-101
Padmanabhan §, Silvet H, Amin J, Pai RG. Prognostic value of QT Picard MH (see Fox et al). 2003:145:730-6
interval and QT dispersion in patients with left ventricular Pichard AD (see Gruberg et al). 2003;145:529-34
systolic dysfunction: results from a cohort of 2265 patients with Piessens J (see Dens et al). 2003;145:404-8 (Progress cardiol.)
an ejection fraction of =40%. 2003:145:132-8 Pilote L (see Simpson et al). 2003;145:438-44
Pagliara V (see Berton et al). 2003;145:1094-1L0 Pimentel G (see Alfonso et al). 2003;145:254-61
Pagnotta P (see Briguori et al). 2003;145:700-7 Pinnow EE (see Gruberg et al). 2003;145:529-34
Pai RG (see Padmanabhan et al). 2003;145:132-8 Piper WD, Malenka DJ, Ryan TJ Jr, Shubrooks SJ Jr, O'Connor GT,
Palatini P (see Berton et al). 2003;145:1094-101 Robb JF, Farrell KL, Corliss MS, Hearne MJ, Kellett MA Jr,
Palmer BF (see Drazner and Palmer). 2003;145:377-9 (Editorial) Watkins MW, Bradley WA, Hettleman BD, Silver TM, McGrath
Palmieri R (see Berton et al). 2003;145:1094-101 PD, O’Mears JR, Wennberg DE, Northern New England Cardio-
Palmieri V, Bella JN, Arnett DK, Oberman A, Kitzman DW, Hopkins vascular Disease Study Group. Predicting vascular complica
PN, Rao DC, Roman MJ, Devereux RB. Associations of aortic and tions in percutaneous coronary interventions. 2003;145:1022-9
mitral regurgitation with body composition and myocardial Pirenne B (see Al-Shwafi et al). 2003;145:217-25 (Progress cardiol.)
energy expenditure in adults with hypertension: the Hyperten- Pitt B (see Rouleau et al). 2003;145:926-32
sion Genetic Epidemiology Network study. 2003;145:1071-7 Plokker HWT (see ten Berg et al). 2003;145:58-65
Palmieri V, Celentano A, Roman MJ, de Simone G, Best L, Lewis MR, Plomondon ME (see Rumsfeld et al). 2003;145:493-9
Robbins DC, Fabsitz RR, Howard BV, Devereux RB. Relation of Pocovi M (see Mozas et al). 2003;145:999-1005
fibrinogen to cardiovascular events is independent of preclini- Podgoreanu MV (see Booth et al). 2003;145:1108-13
cal cardiovascular disease: the Strong Heart Study. 2003;145: Pohorence J (see French et al). 2003;145:118-24
407-74 Pohost G (see Marroquin et al). 2003;145:628-35
Palumbo B, Oguogho A, Sinzinger H. Prostaglandin E, temporarily Poloski L, Gsior M, Wasilewski J, Wilczek K, Wnk A, Adamowicz-
decreases adhesion molecules. 2003;145:e12 (Letter) Czoch E, Sikora J, Lekston A, Zbik T, Gierlotka M, Wojnar R,
Papademetriou V (see Oikarinen et al). 2003;145:919-25 Szkodziski J, Kondys M, Szygua-Jurkiewicz B, Wok R, Zembala
Paquette M (see Newman et al). 2003;145:430-7, 841-6 M. Outcomes of primary coronary angioplasty and angioplasty
Park S-J (see Song et al). 2003;145:371-6 after initial thrombolysis in the treatment of 374 consecutive
Park S-W (see Song et al). 2003:145:371-6 patients with acute myocardial infarction. 2003;145:855-61
Parker MA (see Ricciardi et al). 2003;145:522-8 Popma JJ (see Mauri et al). 2003;145:847-54
Parrinello G (see Licata et al). 2003;145:459-66 Popma JJ (see Resnic et al). 2003;145:42-6
Parrinello G (see Metra et al). 2003;145:292-9 Post CABG Investigators (see Knatterud et al). 2003;145:262-9
Partington S$, Myers J, Cho S, Froelicher V, Chun S$. Prevalence and Poston WSC (see Haddock et al). 2003;145:652-7
prognostic value of exercise-induced ventricular arrhythmias. Poulsen SH (see Moller et al). 2003;145:147-53
2003; 145:139-46 Prasad N (see Mazeika et al). 2003;145:1013-21
Pasquali SK, Alexander KP, Coombs LP, Lytle BL, Peterson ED. Preli RB (see Abdelhamed et al). 2003;145:e15
Effect of cardiac rehabilitation on functional outcomes after Pressler M (see Rajagopalan et al). 2003;145:1114-18
coronary revascularization. 2003;145:445-51 Pressler M (see Russell et al). 2003;145:179-86 (Trial design)
Pastor J (see Bernal-Mizrachi et al). 2003;145:962-70 (Progress car- Prpic R (see Mauri et al). 2003;145:847-54
Pugh PJ, Malkin CJ, Channer KS. To the Editor. 2003;145:e11
diol.)
Patel AD, Iskandrian AE. Role of single photon emission computed (Letter)
Pulsipher M (see Brodie et al). 2003;145:708-15
tomography imaging in the evaluation of therapy for angina
pectoris. 2003;145:952-61 (Curriculum cardiol.) Puzo J (see Mozas et al). 2003;145:999-1005
Paterna S$ (see Licata et al). 2003;145:459-66 Pyne DA (see Russell et al). 2003;145:179-86 (Trial design)
Pauly DF (see Aranda et al). 2003;145:324-9
PCAT Collaborators. Primary coronary angioplasty compared with
intravenous thrombolytic therapy for acute myocardial infarc- Q
tion: six-month follow up and analysis of individual patient data
from randomized trials. 2003;145:47-57 Quinn MJ, Moliterno DJ. Diabetes and percutaneous coronary in-
Pearson TA (see Berry et al). 2003;145: 1036-45 tervention: the sweet smell of success? 2003;145:203-5 (Edito-
Pediatric Pulmonary and Cardiovascular Complications of Vertically rial)
Transmitted HIV Infection Study Group (see Rivenes et al) Quinn RD (see Nowicki et al). 2003;145:1058-62
2003; 145:716-23
Peleg A (see Blum et al). 2003;145:e7
Pellikka PA (see Attenhofer Jost and Pellikka). 2003;145:938-40
(Editorial)
Penn MS (see Moliterno and Penn). 2003;145:563-6 (Editorial) Raineri C (see Gavazzi et al). 2003:145:310-16
Pepine CJ (see Marroquin et al). 2003;145:628-35 Rainville B (see Brassard et al). 2003;145:e25
Pericak-Vance MA (see Hauser et al). 2003;145:602-13 Rajagopalan S$, Mohler E Ill, Lederman RJ, Saucedo J, Mendelsohn
Perna ER, Macin SM, Farias EF, Jantus E. Measurements of serum FO, Olin J, Blebea J, Goldman C, Trachtenberg JD, Pressler M,
cardiac troponin T in patients with heart failure. 2003;145:e19 Rasmussen H, Annex BH, Hirsch AT. Regional angiogenesis
(Letter reply) with vascular endothelial growth factor (VEGF) in peripheral
Person SD (see Ahmed et al). 2003;145: 1086-93 arterial disease: design of the RAVE trial. 2003;145:1114-18
Pescatello LS, Bairos L, VanHeest JL, Maresh CM, Rodriguez NR, Ramanathan K (see French et al). 2003;145:508-14
Moyna NM, DiPasquale C, Collins V, Meckes CL, Krueger L, Rao DC (see Palmieri et al). 2003;145:1071-7
Thompson PD. Postexercise hypotension differs between white Rao SV (see Dery et al). 2003;145:554-62 (Meetings)
and black women. 2003;145:364-70 Rasmussen H (see Rajagopalan et al). 2003;145:1114-18
Petersen JL (see Dery et al). 2003;145:554-62 (Meetings) Ravid S (see Spencer et al). 2003;145:500-7
Peterson ED (see Batchelor et al). 2003;145:349-55 Rea TD, Eisenberg MS. Long-term survival after resuscitation from
Peterson ED (see Pasquali et al). 2003;145:445-51 cardiac arrest: cause for optimism and continued efforts. 2003;
Phillips-Bute B (see Booth et al). 2003;145:1108-13 145:749-50 (Editorial)